LP
DNA.WS

LMR Partners’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

LMR Partners’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,365,816
Closed -$43.8K – 1651
2024
Q2 		$66.7K Hold
2,365,816
– – ﹤0.01% 914
2024
Q1 		$213K Hold
2,365,816
– – ﹤0.01% 860
2023
Q4 		$249K Buy
2,365,816
+954
+0% +$141 ﹤0.01% 721
2023
Q3 		$532K Buy
2,364,862
+616,340
+35% +$166K 0.01% 551
2023
Q2 		$458K Buy
1,748,522
+516,072
+42% +$101K 0.01% 498
2023
Q1 		$1.64M Buy
1,232,450
+44,800
+4% +$10.3K 0.03% 477
2022
Q4 		$2.01M Buy
+1,187,650
New +$509K 0.04% 532
2022
Q2 		– Sell
-206,630
Closed -$833K – 1509
2022
Q1 		$833K Sell
206,630
-1,106,648
-84% -$1.23M 0.01% 874
2021
Q4 		$10.9M Buy
1,313,278
+1,155,911
+735% +$3.74M 0.11% 148
2021
Q3 		$1.82M Buy
+157,367
New +$560K 0.02% 485

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return

LMR Partners's DNA.WS Position: Q3 2024 in Review

LMR Partners sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 2,365,816 shares — an estimated $43.8K sold.

LMR Partners first reported a position in DNA.WS in Q3 2021 and held it in 10 quarters. The position peaked at $10.9M in Q4 2021. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

  • LMR Partners reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
  • LMR Partners sold 2,365,816 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024, an estimated $43.8K.
  • LMR Partners first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 10 quarters.
  • LMR Partners's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $10.9M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on LMR Partners's 13F filing for Q3 2024, filed 7 Nov 2024.